The National Health and Safety Administration (NHS) is closely monitoring the new trends in technolo
Innovations in medicine and technology continue to advance, and the National Health and Safety Administration (NHS) represents a new direction in the industry's cutting edge development. Classification specification Machine-Arm Assisted Operating Price Project Robotic surgical treatment is a cutting-edge technology in the field of surgery, representing innovative power and industrial level. In line with the overall idea of service-based metrics, the metrics guide focuses on the degree of participation of surgical therapeutic robots in surgical treatment and the clinical practice value of promoting precision surgical treatment, the three pricing projects of navigation, participation and precision execution have been established in stages, breaking down the boundaries of surgical treatment entry, application sites, domestic and foreign brands, adopting a relatively pure metrics model, implementing a coefficient charging model linked to main surgical treatment, with higher participation, more comprehensive functionality, performing more precise surgical therapeutic robots to obtain higher cost coefficients, guiding medical institutions to actively prioritize surgical treatment robots for complex surgical treatment.
In recent years, the innovation capacity of surgical treatment robot enterprises has continued to grow, and the speed of product adoption on the market is increasing, providing more options for precise surgical treatment clinical treatment. While supporting the rapid transformation of clinical practices in medical equipment, the Standards Guidance includes patient affordability, explicit pricing of exclusive consumables, such as those necessary for the use of the mechanical arm, and guides enterprises to actively compress the unreasonable price of intermediate flow links, helping to improve the accessibility of mechanical arm auxiliary operations. On the one hand, given the relatively high cost of allocating surgical robotics into early clinical practice, the National Health and Safety Administration (NHS) will guide studies around the establishment of reasonable fee standard thresholds; on the other hand, given the availability of surgical robotics for patients, the National Health and Safety Administration (NHS) will guide the simultaneous establishment of fee standard thresholds across the country, with specific standards to be rationally established by the medical sector in conjunction with factors such as local economic and social development.
All this is necessary to ensure the stability of the innovative development of medical devices and the transmission of signals, to adapt to the new models of surgical treatment in clinical practice, to allow patients to enjoy surgical treatment at the local level by a team of experts from leading medical institutions, to set up separate operating fees for assisted surgical treatment at a distance, to use the platforms for remote operation of surgical treatment devices, to participate in the critical steps or complete all hand treatments at a chargeable rate, to link the price standards to the therapeutic themes, and the specific surgical fee standards to be rationally established by the healthcare sector in all parts of the country. Since 2019, China has successfully implemented the first remote 5G orthopaedic surgical robotic assisted surgery treatment since the start of the first remote 5G orthopaedic surgical assisted surgery treatment, and the intensive promotion of remote surgical treatment in various disciplines in Beijing, Shanghai, Zhejiang, and other places. In November 2025, the world's first remote robotic retina injection surgery treatment was successfully completed in Guangzhou and Xinjiang.
Moving remote surgical therapy into clinical practice will directly drive technological innovation in relevant fields, generating timely feedback on surgical treatment mechanical arms, clearer navigation equipment in the field of view, more accurate data monitoring equipment, and further driving the development of medical equipment. Pricing policies have opened up the last kilometre of long-distance surgical treatment to be explored formally from the forefront of clinical practice towards practical applications, and patients, medical institutions and pharmaceutical companies are expected to achieve multilateral benefits, promoting the expansion of quality medical resources across regions, improving the availability of quality medical resources, and innovating classified clinical models. In recent years, the healthcare sector has been guiding companies through centralized bandwidth procurement and other methods to reduce unreasonable price increases in supply chains, and significantly reducing the price of assistive devices such as ultrasound knives and machine tools.
Regulations for reusable consumables and disposable consumables reimbursement policies Electrical tools, ultrasound tools, RF tools, microwave tools, plasma tools, etc. are the most commonly used auxiliary devices in clinical practice and are widely used in clinical practice. Considering that auxiliary operating costs are mainly clinical practical values and use costs of consumable equipment, the Standardization Guide summarizes previous local price work experience, further clarifying the cost of disposable consumables and the corresponding auxiliary operating costs cannot be charged simultaneously.
Given that most consumables such as electrical tools, ultrasonic tools and RF tools have two types of single use and reusable, the average cost of allocation of reusable consumables is relatively fixed, and the price of single-use consumables at different specifications varies greatly, some companies are more inclined to register reusable consumables as single-use consumables, and reusable consumables tend to marginalise gradually. Clear policies to reduce the shortage of medical data to ensure the quality control and traceability of mechanical arm surgical treatments, remote surgical treatments, statistical guidelines to incorporate the cost of storage of medical data, equipment operation records, medical institutions to promote 3D reconstruction of medicine, surgical treatment path navigation, surgical treatment of mechanical arms, remote surgical treatment, and other ancillary operations, to preserve and upload medical data and equipment operation records that meet the requirements, without providing data storage and upload services, will implement the policy to reduce the collection. For example, medical institutions use single-use ultrasound knife heads, single-use ultrasound knife heads sold at a discounted rate, no longer charging the operating fee; medical institutions use repeatable ultrasound knife heads, directly charging the operating fee.
Through in-depth analysis of quantitative, real, continuous equipment operation and clinical practice outcome data, the medical sector is able to work with medical institutions, enterprises and expert teams to build scientific therapeutic efficacy and efficacy assessment models to better optimize the clinical practical value of surgical robots. On this basis, continuously optimize the path of application of technology, accelerate the development of new techniques, and explore and cultivate innovative scenarios such as remote medicine, intelligent navigation, and advance the development of cutting-edge technologies from the point of use to the point of use. China's international healthcare system keeps track of the latest developments in the field of medical health to provide you with authority, reliable information and medical services.
If you have further consultation needs, please contact authoritative experts via the platform.
